400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Cell Cycle / Chk / (R)-2-Amino-2-cyclohexyl-N-(5-(1-methyl-1H-pyrazol-4-yl)-1-oxo-2,6-dihydro-1H-[1,2]diazepino[4,5,6-cd]indol-8-yl)acetamide
CAS No.: 952021-60-2
Synonyms: PF 00477736;PF-736
PF-477736 is a selective, potent and ATP-competitive Chk1 inhibitor with Ki of 0.49 nM and also inhibits VEGFR2, Aurora-A, FGFR3, Flt3, Fms (CSF1R), Ret and Yes and shows ~100-fold selectivity for Chk1 than Chk2.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT00437203 | Neoplasms | Phase 1 | Terminated(See termination rea... more >>son in detailed description.) Collapse << | - | United States, California ... more >> Pfizer Investigational Site Los Angeles, California, United States, 90095-6984 Pfizer Investigational Site Los Angeles, California, United States, 90095 Pfizer Investigational Site Santa Monica, California, United States, 90403 Pfizer Investigational Site Santa Monica, California, United States, 90404 United States, New York Pfizer Investigational Site New York, New York, United States, 10022 Pfizer Investigational Site New York, New York, United States, 10065 Australia, Victoria Pfizer Investigational Site East Melbourne, Victoria, Australia, 3002 Collapse << |
NCT00437203 | - | - | Terminated(See termination rea... more >>son in detailed description.) Collapse << | - | - |
实验方案
技术信息
CAS号 | 952021-60-2 | 储存条件 |
|
|||||||||||
分子式 | C22H25N7O2 | 运输 | 蓝冰 | |||||||||||
分子量 | 419.48 | 别名 | PF 00477736;PF-736 | |||||||||||
溶解度 |
|
动物实验配方 |
|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT00437203 | Neoplasms | Phase 1 | Terminated(See termination rea... more >>son in detailed description.) Collapse << | - | United States, California ... more >> Pfizer Investigational Site Los Angeles, California, United States, 90095-6984 Pfizer Investigational Site Los Angeles, California, United States, 90095 Pfizer Investigational Site Santa Monica, California, United States, 90403 Pfizer Investigational Site Santa Monica, California, United States, 90404 United States, New York Pfizer Investigational Site New York, New York, United States, 10022 Pfizer Investigational Site New York, New York, United States, 10065 Australia, Victoria Pfizer Investigational Site East Melbourne, Victoria, Australia, 3002 Collapse << |
NCT00437203 | - | - | Terminated(See termination rea... more >>son in detailed description.) Collapse << | - | - |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网